Aspirin acetylation of betaLys-82 of human hemoglobin. NMR study of acetylated hemoglobin Tsurumai.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochemical Pharmacology

• Publication date

  2000-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(00)00419-6PMID 10974199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on aspirin in the treatment and prevention of cardiovascular disease.

  1999cited by this paper
• An NMR analysis of the reaction of ubiquitin with [acetyl-1-13C]aspirin.

  1999cited by this paper
• Management of sickle cell disease.

  1999cited by this paper
• NMR study of the sites of human hemoglobin acetylated by aspirin.

  1999cited by this paper
• Acetylation of Human Hemoglobin by Methyl Acetylphosphate

  1999cited by this paper
• Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group.

  1996cited by this paper
• Hb Tsurumai [beta 82(EF6)Lys-->Gln]: a new Hb variant with high oxygen affinity and erythrocytosis.

  1996cited by this paper
• Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer.

  1995cited by this paper
• High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin.

  1994cited by this paper
• Acetylsalicylic acid and acetaminophen.

  1994cited by this paper
• Transport of aspirin and its metabolites through human erythrocyte membrane.

  1993cited by this paper
• Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes.

  1993cited by this paper
• Acetylsalicylate-human serum albumin interaction as studied by NMR spectroscopy--antigenicity-producing mechanism of acetylsalicylic acid.

  1991cited by this paper
• Acetylsalicylate-human serum albumin interaction as studied by NMR spectroscopy--antigenicity-producing mechanism of acetylsalicylic acid.

  1991cited by this paper
• Methyl acetyl phosphate as a covalent probe for anion-binding sites in human and bovine hemoglobins.

  1989cited by this paper
• Site-specific modification of hemoglobin by methyl acetyl phosphate.

  1986cited by this paper
• Treatment of sickle cell diseases with aspirin.

  1984cited by this paper
• The relative roles of hydrolases of the erythrocyte and other tissues in controlling aspirin survival in vivo.

  1984cited by this paper
• Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.

  1984cited by this paper
• Trial of low doses of aspirin as prophylaxis in sickle cell disease.

  1983cited by this paper
• Aspirin survival in human blood modulated by the concentration of erythrocytes.

  1982cited by this paper
• Rational approaches to chemotherapy: antisickling agents.

  1981cited by this paper
• Therapeutic effect of aspirin in sickle cell anaemia.

  1981cited by this paper
• Development of antisickling compounds that chemically modify hemoglobin S specifically within the 2,3-diphosphoglycerate binding site.

  1980cited by this paper
• Modification of hemoglobin with analogs of aspirin.

  1980cited by this paper
• Diaspirins that cross-link beta chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate.

  1979cited by this paper
• The acetylation of hemoglobin by aspirin. In vitro and in vivo.

  1975cited by this paper
• Sites of acetylation of sickle cell hemoglobin by aspirin.

  1974cited by this paper
• Acetylation of sickle cell hemoglobin by aspirin.

  1973cited by this paper
• The effect of aspirin on sickling and oxygen affinity of erythrocytes.

  1973cited by this paper
• X-ray Diffraction Study of Binding of 2,3-Diphosphoglycerate to Human Deoxyhaemoglobin

  1972cited by this paper
• Structure and function of hemoglobin.

  1969cited by this paper

• Comparative study of lysine acetylation in Vesicomyidae clam Archivesica marissinica and the manila clam Ruditapes philippinarum: adaptation mechanisms in cold seep environments

  2024cites this paper
• Modulating the microtubule-tau interactions in biomotility systems by altering the chemical environment.

  2016cites this paper
• Historical Development of Biomarkers

  2016cites this paper
• Furan-based acetylating agent for the chemical modification of proteins.

  2015cites this paper
• Comparison of Protein Acetyltransferase Action of CRTAase with the Prototypes of HAT

  2014cites this paper
• - Blood, Plasma, Cells, and Other Biological Fluids

  2012cites this paper
• Identification of rat and human hemoglobin acetylation sites formed as a result of interaction with acetylsalicylic acid

  2012cites this paper
• [Identification of rat and human hemoglobin acetilation sites after its interaction with acetylsalicylic acid].

  2012cites this paper
• Role of fibrin structure in thrombosis and vascular disease.

  2011cites this paper
• The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.

  2010cites this paper
• Spectroscopic studies of the interaction of aspirin and its important metabolite, salicylate ion, with DNA, A·T and G·C rich sequences.

  2010cites this paper
• Does aspirin acetylate multiple cellular proteins? (Review).

  2009cites this paper
• Protein-reactive natural products.

  2005cites this paper
• Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

  2005cites this paper